Digital Intervention Promoting Physical Activity Among Obese People (DIPPAO)

Summary

Overweight and obesity are today considered among the most important health risks facing humanity with more than one in two adults overweight or obese in western countries. In addition, Type 2 diabetes mellitus (T2DM) is a common comorbidity associated with overweight and obesity and counts for 5% of the French population under 65 years of age and 15% in people over 65 years old. Despite the accumulation of scientific evidence supporting the benefits of physical activity, obese and diabetic people remain insufficiently active and current programs struggle to engage and sustain physical activity of patients over long periods of time. It is therefore urgent to develop interventions that can effectively change individuals' behavior. In this context, "e-health" interventions and gamification appear to be a particularly promising avenue to improve physical activity and reduce attrition rates of current programs.

This clinical trial aim to test the effectiveness of a digital intervention based on gamification and teamwork in comparison to a supervised physical activity program. The investigators hypothesized that the intervention will be efficient by the development of a self-determined motivation through the process of gamification on the one hand. On the other hand, through the in-group collaboration with other people who share the same stigmatized criteria that will help participants to overcome weight stigmas, acting generally as physical activity barriers.

Conditions

• Obesity
• Diabete Type 2

Interventions

DEVICE

Kiplin

The Kiplin intervention will be composed of four components within a smartphone application: a) a gamification of Physical Activity through multiple games called "animations", b) a remote adapted physical activity program with telecoaching sessions, c) an interface for exchange and conversation and, d) an activity monitoring tool.

BEHAVIORAL

face-to-face

three-month program of face-to-face adapted physical activity, three sessions a week, for a total of 36 sessions.

Sponsors & Collaborators

• SENS laboratory, Univ. Grenoble Alpes

  collaborator UNKNOWN

• INRAE, UNH, CRNH Auvergne, Clermont Auvergne University

  collaborator UNKNOWN

• Kiplin

  collaborator UNKNOWN

• I-SITE Clermont Auvergne Project 20-25

  collaborator UNKNOWN

• University Hospital, Clermont-Ferrand

  lead OTHER

Principal Investigators

• Martine Duclos · University Hospital, Clermont-Ferrand

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-06-10

Primary Completion

2023-10-15

Completion

2023-10-15

Countries

• France

Study Locations